Relieves arthritis and esomeprazole magnesium. ANDA 204206, held by Dr. Reddy's Laboratories. Esomeprazole Magnesium; Naproxen.
As of Nov 21, 2026, ANDA 204206 (Naproxen and Esomeprazole Magnesium), held by Dr. Reddy's Laboratories, was first approved by FDA on Feb 18, 2020, with 6 approved supplements and 0 published complete response letters.
Naproxen and esomeprazole magnesium delayed-release tablets, a combination of naproxen and esomeprazole magnesium, is indicated in adult and adolescent patients 12 years of age and older weighing at least 38 kg, requiring naproxen for symptomatic relief of arthritis and esomeprazole magnesium to decrease the risk for developing naproxen-associated gastric ulcers. The naproxen component of naproxen and esomeprazole magnesium delayed-release tablet is indicated for relief of signs and symptoms of:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 18, 2020 | Original application | Approved |
| Naproxen and Esomeprazole MagnesiumEQ 20MG BASE;375MG · tablet, delayed release;oral | Esomeprazole Magnesium; Naproxen | Rx |
| Naproxen and Esomeprazole MagnesiumEQ 20MG BASE;500MG · tablet, delayed release;oral | Esomeprazole Magnesium; Naproxen | Rx |
| Mar 21, 2025 | Supplement 10Labeling · Standard review | Approved | None posted |
| Nov 21, 2024 | Supplement 4Labeling · Standard review | Approved | None posted |
| Nov 21, 2024 | Supplement 5Labeling · Standard review | Approved | None posted |
| Nov 21, 2024 | Supplement 6Labeling · Standard review | Approved | None posted |
| Nov 21, 2024 | Supplement 7Labeling · Standard review | Approved | None posted |
| Nov 21, 2024 | Supplement 9Labeling · Standard review | Approved | None posted |
| Feb 18, 2020 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters